Lea Almeida

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 13

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology (2024)
Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto M Lang, Gergely Tekes, Volker Thiel
An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology 98 (2) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology (2024)
Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto M Lang, Gergely Tekes, Volker Thiel
An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology 98 (2) (2024)
Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto M Lang, Gergely Tekes, Volker Thiel
An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology 98 (2) (2024)
Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto M Lang, Gergely Tekes, Volker Thiel
An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology 98 (2) (2024)
Kimberly Schmied, Rosina Ehmann, Claudia Kristen-Burmann, Nadine Ebert, Güliz Tuba Barut, Lea Almeida, Jenna N Kelly, Lisa Thomann, Hanspeter Stalder, Reto M Lang, Gergely Tekes, Volker Thiel
An RNA replicon system to investigate promising inhibitors of feline coronavirus. Journal of virology (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)
Jacob Schön, Güliz Tuba Barut, Bettina Salome Trueeb, Nico Joël Halwe, Inês Berenguer Veiga, Annika Kratzel, Lorenz Ulrich, Jenna N Kelly, Melanie Brügger, Christoph Langner, Adriano Taddeo, Etori Aguiar Moreira, Demeter Túrós, Llorenç Grau-Roma, Ann Kathrin Ahrens, Kore Schlottau, Tobias Britzke, Angele Breithaupt, Björn Corleis, Jana Kochmann, Blandina I Oliveira Esteves, Lea Almeida, Lisa Thomann, Christelle Devisme, Hanspeter Stalder, Silvio Steiner, Sarah Ochsenbein, Kimberly Schmied, Fabien Labroussaa, Joerg Jores, Philip V'kovski, Vladimir Cmiljanovic, Marco P Alves, Charaf Benarafa, Nadine Ebert, Donata Hoffmann, Martin Beer, Volker Thiel
A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nature microbiology 9 (8) (2024)